Pranshu Mohindra, MD, MBBS, on Considering Intensity-Modulated Proton Therapy–Based Reirradiation for Patients With NSCLC

Posted: Wednesday, February 2, 2022

Pranshu Mohindra, MD, MBBS, of the University of Maryland School of Medicine and the Maryland Proton Treatment Center, discusses his findings on the benefits of intensity-modulated proton therapy–based reirradiation for patients with non–small cell lung cancer and the feasibility of offering this treatment to all patients with this type of lung cancer.